Viewing nowRosutero Tablet 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

MFDS item code 201405004 · Approved 2014.10.29 · Insurance code 646003850
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
This medication is primarily used as an adjunct in patients with primary hypercholesterolemia and familial hypercholesterolemia, and mixed hyperlipidemia when diet and exercise are not enough to control these conditions. It also plays a role in lowering total cholesterol and LDL cholesterol levels, thereby delaying the progression of atherosclerosis. It may be administered as an adjunct to diet for pediatric patients between the ages of 10 and 17 who exceed specific cholesterol criteria. It is beneficial for patients with primary dysbetalipoproteinemia and is used to reduce the risk of stroke, myocardial infarction, and risks associated with arterial revascularization in middle-aged and older men and women with a high risk of cardiovascular disease. This medication is effective in decreasing dyslipidemia and cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams per day. 3. Older adults: Dose adjustment is not necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. Safety and efficacy have not been established in children under 10 years of age.
This medication should not be administered to certain patients. For example, it should not be used in patients with allergies to its components, liver function issues, muscle diseases, severe renal impairment, or women who are pregnant or breastfeeding. Additionally, high-dose administration is prohibited in patients at risk for myopathy or rhabdomyolysis. This medication contains lactose, and should not be given to patients with lactose intolerance. Regular monitoring of liver function tests and muscle condition is necessary while using this medication. Special caution is warranted for patients with a history of liver disease or excessive alcohol consumption. If symptoms such as muscle pain, weakness, or cramps occur, medical professionals should be notified immediately, and discontinuation of the medication may be necessary. This medication may interact with other medications, so patients must inform their doctor or pharmacist of any other drugs they are taking. In particular, muscle toxicity risk may increase when used in conjunction with certain antiviral agents, immunosuppressants, and fibrate drugs. Women of childbearing potential should use appropriate contraceptive methods when taking this medication, and should avoid use during pregnancy or lactation. In cases of overdose, there is no specific antidote, so treatment according to symptoms and monitoring of liver and muscle conditions is required. Dizziness may occur when driving or operating machinery, so caution is advised. Lastly, this medication may exhibit higher blood concentrations in Asians, so dose adjustments may be necessary.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, transaminase increase, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, ALT increase, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1°C and 30°C.
Pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.